Page Title
Clinical Trial Finder
Observational Closed to Enrollment
Phase 4 TOBI Podhaler observational study (Novartis CTBM100C2407)
This study is taking place at multiple care centers across the U.S. It will look at the effectiveness and long term safety of the TOBI Podhaler and other FDA-approved inhaled antipseudomonal drugs.
This observational study will look at the effectiveness and long term safety of the TOBI Podhaler and other FDA-approved antipseudomonal drugs. Researchers will test the effectiveness of these drugs by measuring lung function and the amount of Pseudomonas aeruginosa in sputum. They will also track pulmonary exacerbations and other measures.This study is for people with cystic fibrosis who have a chronic Pseudomonas aeruginosa infection. This study may require lung function tests, sputum cultures and/or other measurements.
Eligibility
-
Age:
6 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
25 to 80%
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Study Design
-
Study Type: ?more info
Observational -
Randomized Study: ?more info
No -
Placebo Controlled: ?more info
No -
Length of Participation:
60 months -
Number of Study Visits:
22
Additional Information
-
Phase: ?more info
Phase Four/Post-Approval -
Study Sponsor: ?more info
Novartis -
Study Drugs:
N/A
Study Sites
-
Closed to Enrollment
Alaska
Providence Alaska Medical Center, Anchorage, AK 99508
-
Closed to Enrollment
Arkansas
Arkansas Children's Hospital, Little Rock, AR 72202
-
Closed to Enrollment
California
Children's Hospital of Los Angeles, Los Angeles, CA 90027
-
Closed to Enrollment
California
Center for Cystic Fibrosis at Keck Medical Center of USC, Los Angeles, CA 90033
-
Closed to Enrollment
California
Valley Children’s Cystic Fibrosis Center in affiliation with Stanford School of Medicine, Madera, CA 93636
-
Closed to Enrollment
California
Kaiser Permanente Southern California CF Center, Los Angles, CA 90027
-
Closed to Enrollment
Connecticut
Yale University School of Medicine, New Haven, CT 06520
-
Closed to Enrollment
Connecticut
The Marie and Raymond Beauregard Adult CF Center at Hartford Hospital, Hartford, CT 06102
-
Closed to Enrollment
Florida
Central Florida Pulmonary Group, Orlando, FL 32803
-
Closed to Enrollment
Florida
Tampa General Hospital, Tampa, FL 33606
-
Closed to Enrollment
Florida
University of Florida, Gainesville, FL 32610
-
Closed to Enrollment
Georgia
Children’s Healthcare of Atlanta and Emory University, Atlanta, GA 30322
-
Closed to Enrollment
Georgia
Augusta University, Augusta, GA 30912
-
Closed to Enrollment
Idaho
Saint Luke's Cystic Fibrosis Center of Idaho, Boise, ID 83702
-
Closed to Enrollment
Illinois
Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL 60611
-
Closed to Enrollment
Indiana
Riley Hospital for Children, Indianapolis, IN 46202
-
Closed to Enrollment
Iowa
University of Iowa, Iowa City, IA 52242
-
Closed to Enrollment
Kansas
University of Kansas Medical Center, Kansas City, KS 66160
-
Closed to Enrollment
Louisiana
Tulane University, New Orleans, LA 70112
-
Closed to Enrollment
Massachusetts
Boston Children's Hospital, Boston, MA 02115
-
Closed to Enrollment
Michigan
Helen DeVos Children's Hospital, Grand Rapids , MI 49503
-
Closed to Enrollment
Michigan
Children's Hospital of Michigan, Detroit, MI 48201
-
Closed to Enrollment
Missouri
Children's Mercy Kansas City, Kansas City, MO 64108
-
Closed to Enrollment
Montana
Billings Clinic , Billings, MT 59101
-
Closed to Enrollment
Nebraska
University of Nebraska Medical Center, Omaha, NE 68114
-
Closed to Enrollment
New Jersey
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
-
Closed to Enrollment
New York
Long Island Jewish Medical Center, New Hyde Park, NY 11042
-
Closed to Enrollment
New York
Cohen Children's Medical Center of New York, Lake Success, NY 11042
-
Closed to Enrollment
New York
Children's Hospital of New York, New York, NY 10032
-
Closed to Enrollment
North Carolina
Wake Forest University Baptist Medical Center, Winston-Salem, NC 27157
-
Closed to Enrollment
Ohio
Children's Hospital Medical Center of Akron, Akron, OH 44308
-
Closed to Enrollment
Oklahoma
Oklahoma Cystic Fibrosis Center, OKC, OK 73104
-
Closed to Enrollment
Pennsylvania
Hershey Medical Center Pennsylvania State University, Hershey, PA 17033
-
Closed to Enrollment
Pennsylvania
University of Pennsylvania, Philadelphia, PA 19104
-
Closed to Enrollment
South Dakota
Sanford USD Medical Center, Sioux Falls, SD 57117
-
Closed to Enrollment
Tennessee
Vanderbilt Children's Hospital, Nashville, TN 37232
-
Closed to Enrollment
Texas
University of Texas Southwestern / Children’s Health, Dallas, TX 75207
-
Closed to Enrollment
Texas
University of Texas Health Center at Tyler, Tyler, TX 9038775271
-
Closed to Enrollment
Texas
Dell Children's Medical Center of Central Texas, Austin, TX 78723
-
Closed to Enrollment
Utah
Intermountain Cystic Fibrosis Center, University of Utah, Salt Lake City, UT 84132
-
Closed to Enrollment
Vermont
University of Vermont Medical Center, Burlington, VT 05401
-
Closed to Enrollment
Vermont
Vermont Children's Hospital, Burlington, VT 05401
-
Closed to Enrollment
Virginia
Virginia Commonwealth University, Richmond, VA 23219
-
Closed to Enrollment
Washington
Providence Medical Group, Cystic Fibrosis Clinic, Spokane, WA 99204
-
Closed to Enrollment
Wisconsin
Froedtert & Medical College of Wisconsin, Milwaukee, WI 53226
Eligibility
-
Age:
6 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
25 to 80% -
Pseudomonas Status:
Positive Respiratory Cultures Required
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Related Topics
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More